Targeted deletion of RasGRP1 impairs skin tumorigenesis

Amrish Sharma, Lauren L. Fonseca, Cynthia Rajani, Jodi K. Yanagida, Yuka Endo, J. Mark Cline, James C. Stone, Junfang Ji, Joe W. Ramos, Patricia S. Lorenzo

Research output: Contribution to journalArticle

11 Scopus citations

Abstract

Ras is frequently activated in cutaneous squamous cell carcinoma, a prevalent form of skin cancer. However, the pathways that contribute to Ras-induced transformation have not been entirely elucidated. We have previously demonstrated that in transgenic mice, overexpression of the Ras activator RasGRP1 promotes the formation of spontaneous skin tumors and enhances malignant progression in the multistage carcinogenesis skin model that relies on the oncogenic activation of H-Ras. Utilizing a RasGRP1 knockout mouse model (RasGRP1 KO), we now show that lack of RasGRP1 reduced the susceptibility to skin tumorigenesis. The dependency on RasGRP1 was associated with a diminished response to the phorbol ester tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA). Specifically, we found impairment of epidermal hyperplasia induced by TPA through keratinocyte proliferation. Using a keratinocyte cell line that carries a ras oncogenic mutation, we also demonstrated that RasGRP1 could further activate Ras in response to TPA. Thus, we propose that RasGRP1 upregulates signaling from Ras and contributes to epidermal tumorigenesis by increasing the total dosage of active Ras.

Original languageEnglish (US)
Pages (from-to)1084-1091
Number of pages8
JournalCarcinogenesis
Volume35
Issue number5
DOIs
StatePublished - Apr 2014

    Fingerprint

ASJC Scopus subject areas

  • Cancer Research

Cite this

Sharma, A., Fonseca, L. L., Rajani, C., Yanagida, J. K., Endo, Y., Cline, J. M., Stone, J. C., Ji, J., Ramos, J. W., & Lorenzo, P. S. (2014). Targeted deletion of RasGRP1 impairs skin tumorigenesis. Carcinogenesis, 35(5), 1084-1091. https://doi.org/10.1093/carcin/bgu016